Peptides, the life's labor force of molecules, are becoming more and more important in a variety of domains, such as research, diagnostics, and therapies. Peptide synthesis was once thought to be a specialized field, but it has grown into a booming industry with many uses. This blog explores the factors that drive the trajectory of the peptide synthesis market by looking at new trends, obstacles, and possibilities.
According to BCC Research, The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
Peptide therapies have attracted a lot of interest because of their excellent safety, effectiveness, and specificity profiles. The market for specially created peptides is still growing, with applications ranging from insulin analogs to more recent peptide-based medications for cancer and metabolic diseases. The need for customized peptide therapies that target particular biochemical pathways is growing as precision medicine gains traction, which is propelling the peptide synthesis market's expansion.